Search Within

Heiko Schoder

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (75)
  2. Meeting Abstract (63)
  3. Review (6)
  4. Editorial (3)
  5. Guidelines (2)
  6. Research Letter (2)
  7. Book Section (1)
  8. Miscellaneous (1)
Groups
  1. Molecular Imaging and Therapy Service (153)
  2. Radiology, Department of (153)
  3. Sloan Kettering Institute Postdocs (153)
  4. Department of Medicine (92)
  5. Epidemiology and Biostatistics (65)
  6. Biostatistics Service (61)

More Groups

People
  1. John Humm (41)
  2. Maria Palomba (32)
  3. Milan Grkovski (31)
  4. Gilles Salles (30)
  5. Laure Michaud (29)
  6. Audrey Mauguen (28)

More People

Years
  1. 2025 (10)
  2. 2024 (22)
  3. 2023 (27)
  4. 2022 (18)
  5. 2021 (24)
  6. 2020 (16)

More Years

Publications
  1. Journal of Nuclear Medicine (33)
  2. European Journal of Nuclear Medicine and Molecular Imaging (19)
  3. Blood (17)
  4. International Journal of Radiation Oncology, Biology, Physics (8)
  5. Journal of Clinical Oncology (8)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. Society of Nuclear Medicine (33)
  2. Springer (28)
  3. American Society of Hematology (19)
  4. Elsevier Inc. (14)
  5. American Society of Clinical Oncology (8)
  6. American Association for Cancer Research (7)

More Publishers

Results (153)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune signature of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Ganesan, N.; Shah, G. L.; Wong, P.; Argyropoulos, K. V.; Sen, F.; Dogan, A.; Straus, D. J.; Noy, A.; Kumar, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Correlative biomarkers for CART19 response in patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Batlevi, C. L.; Nos, G.; Kotlov, N.; Sorokina, M.; Okwali, M.; Bagaev, A.; Michaud, L.; Shah, G. L.; Shouval, R.; Tomas, A. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Brentuximab vedotin combined with chemotherapy in newly diagnosed, early-stage, unfavorable-risk Hodgkin lymphoma: Extended follow-up with evaluation of baseline metabolic tumor volume and PET2
    Meeting Abstract

    Stuver, R.; Michaud, L.; Casulo, C.; Advani, R. H.; Budde, E. L.; Barr, P. M.; Batlevi, C. L.; Caron, P. C.; Constine, L. S.; Dandapani, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Imaging cellular immunotherapies and immune cell biomarkers: From preclinical studies to patients
    Review

    Volpe, A.; Adusumilli, P. S.; Schöder, H.; Ponomarev, V.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated high-grade neuroendocrine tumors to lutetium-177-DOTATATE
    Journal Article

    Raj, N.; Coffman, K.; Le, T.; Do, R. K. G.; Rafailov, J.; Choi, Y.; Chou, J. F.; Capanu, M.; Dunphy, M.; Fox, J. J.; more...
    Neuroendocrinology (2022)

    Fulltext@MSK | Save
  • Impact of ComBat harmonization on PET radiomics-based tissue classification: A dual-center PET/MRI and PET/CT study
    Journal Article

    Leithner, D.; Schöder, H.; Haug, A.; Vargas, H. A.; Gibbs, P.; Häggström, I.; Rausch, I.; Weber, M.; Becker, A. S.; Schwartz, J.; more...
    Journal of Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • Patterns of relapse and risk reduction following tumor debulking by bridging radiotherapy prior to chimeric antigen receptor T cell therapy in non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Michaud, L.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Alarcon Tomas, A.; Shouval, R.; Palomba, M. L.; Batlevi, C. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Intra-treatment tumor apparent diffusion coefficient, a quantitative imaging metric, is associated with neck nodal recurrence in de-escalated treatment of HPV-positive oropharyngeal cancer (OPC)
    Meeting Abstract

    Diplas, B.; Han, J.; Paudyal, R.; Oh, J. H.; Sherman, E.; Schoder, H.; Hatzoglou, V.; Yu, Y.; Wong, R. J.; Wray, R.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Development and validation of diagnostic interpretation criteria for evaluation of F-18 Fluoromisonidazole hypoxia PET/CT – Inter-reader reliability and accuracy
    Meeting Abstract

    Wray, R.; Mauguen, A.; Michaud, L.; Leithner, D.; Sherman, E.; Riaz, N.; Humm, J.; Mirtcheva, R.; Boyle, J. O.; Wong, R. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Tumor volume predicts for baseline hypoxia status in HPV related oropharyngeal carcinomas (OPC) that underwent major radiation de-escalation: The 30 Reduction in Oropharyngeal Cancer Trial
    Meeting Abstract

    Han, J.; Diplas, B.; Paudyal, R.; Oh, J. H.; Sherman, E.; Schoder, H.; Hatzoglou, V.; Yu, Y.; Wong, R. J.; Wray, R.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save